First Trust Advisors
PRPH

First Trust Advisors’s ProPhase Labs PRPH Stock Holding History

First Trust Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,733
Closed -$271K – 2466
2023
Q2 		$271K Buy
3,733
+222
+6% +$18.1K ﹤0.01% 2254
2023
Q1 		$268K Buy
3,511
+268
+8% +$21.6K ﹤0.01% 2261
2022
Q4 		$312K Sell
3,243
-167
-5% -$18K ﹤0.01% 2305
2022
Q3 		$385K Buy
+3,410
New +$397K ﹤0.01% 2288

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

First Trust Advisors's PRPH Position: Q3 2023 in Review

First Trust Advisors sold out of ProPhase Labs (PRPH) in Q3 2023, closing a stake of 3,733 shares — an estimated $271K sold.

First Trust Advisors first reported a position in PRPH in Q3 2022 and held it in 4 quarters. The position peaked at $385K in Q3 2022. 35 funds tracked by Wall St. Rank hold PRPH as of Q3 2023.

  • First Trust Advisors reported no remaining ProPhase Labs position as of Q3 2023 after selling out during the quarter.
  • First Trust Advisors sold 3,733 ProPhase Labs shares in Q3 2023, an estimated $271K.
  • First Trust Advisors first reported a position in ProPhase Labs in Q3 2022 and held it in 4 quarters.
  • First Trust Advisors's ProPhase Labs position peaked at $385K in Q3 2022.
  • 35 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2023.

Based on First Trust Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.